Cargando…
Combinatorial Effects of Thymoquinone on the Anticancer Activity and Hepatotoxicity of the Prodrug CB 1954
BACKGROUND: One of the major causes of clinical trial termination is the liver toxicity induced by chemotherapeutic agents. Treatment with anticancer drugs like CB 1954 (5-(Aziridin-1-yl)-2,4-dinitrobenzamide) is associated with significant hepatotoxicity. Thymoquinone (TQ), extracted from Nigella s...
Autores principales: | Talib, Wamidh H., AbuKhader, Majed M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700079/ https://www.ncbi.nlm.nih.gov/pubmed/23833717 http://dx.doi.org/10.3797/scipharm.1211-15 |
Ejemplares similares
-
Thymoquinone in the clinical treatment of cancer: Fact or fiction?
por: AbuKhader, Majed M.
Publicado: (2013) -
The Effect of Route of Administration in Thymoquinone Toxicity in Male and Female Rats
por: AbuKhader, M. M.
Publicado: (2012) -
E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954
por: Vass, S O, et al.
Publicado: (2009) -
Regressions of Breast Carcinoma Syngraft Following Treatment with Piperine in Combination with Thymoquinone
por: Talib, Wamidh H.
Publicado: (2017) -
Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracil
por: Palmer, D H, et al.
Publicado: (2003)